Atkins MB, McDermott DF, Powles T, et al. IMmotion150: A phase II trial in untreated metastatic renal cell carcinoma (mRCC) patients (pts) of atezolizumab (atezo) and bevacizumab (bev) vs and following atezo or sunitinib (sun). J Clin Oncol 35, 2017 (suppl; abstr 4505).
Analyse van circulerend tumor-DNA bij patiënten met ‘ALK’-positieve longkanker
dec 2019 | Longoncologie